BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 15749639)

  • 21. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA).
    Lee YY; Choi CH; Kim CJ; Song TJ; Kim MK; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
    Gynecol Oncol; 2010 Mar; 116(3):459-63. PubMed ID: 20004008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organ preservation in locally advanced carcinoma of the uterine cervix.
    Smaniotto D; Andrulli AD; Tortoreto F; Niespolo RM; Valentini V
    Rays; 1997; 22(3):472-7. PubMed ID: 9446953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
    Fritz P; Stoll P; Wannenmacher M; Zierhut D
    Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
    Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent chemoradiation in locally advanced carcinoma cervix patients.
    Negi RR; Gupta M; Kumar M; Gupta MK; Seam R; Rastogi M
    J Cancer Res Ther; 2010; 6(2):159-66. PubMed ID: 20622362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sobel E; Rose GS; Thomas G; Carlson JW
    Gynecol Oncol; 2004 Aug; 94(2):495-501. PubMed ID: 15297194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer.
    Chen CC; Lin JC; Jan JS; Ho SC; Wang L
    Gynecol Oncol; 2011 Jul; 122(1):9-13. PubMed ID: 21514629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer.
    Dubay RA; Rose PG; O'Malley DM; Shalodi AD; Ludin A; Selim MA
    Gynecol Oncol; 2004 Jul; 94(1):121-4. PubMed ID: 15262129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer.
    Roof KS; Coen J; Lynch TJ; Wright C; Fidias P; Willett CG; Choi NC
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1120-8. PubMed ID: 16730135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma.
    Jones EL; Samulski TV; Dewhirst MW; Alvarez-Secord A; Berchuck A; Clarke-Pearson D; Havrilesky LJ; Soper J; Prosnitz LR
    Cancer; 2003 Jul; 98(2):277-82. PubMed ID: 12872345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
    Kurita H; Koike T; Miyazawa H; Uehara S; Kobayashi H; Kurashina K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):915-21. PubMed ID: 16835480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer.
    Thomas G; Dembo A; Ackerman I; Franssen E; Balogh J; Fyles A; Levin W
    Gynecol Oncol; 1998 May; 69(2):137-45. PubMed ID: 9600821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil--a phase II study.
    Fuwa N; Shikama N; Hayashi N; Matsuzuka T; Toita T; Yuta A; Oonishi H; Kodaira T; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Oct; 43(9):948-55. PubMed ID: 17257880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.